中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial Reply

文献类型:期刊论文

作者Yu, Yang2; Zong, Xiangyun1
刊名JAMA ONCOLOGY
出版日期2022-04-14
ISSN号2374-2437
DOI10.1001/jamaoncol.2022.0491
通讯作者Zong, Xiangyun(tigerzong@msn.com)
WOS研究方向Oncology
语种英语
WOS记录号WOS:000782627500007
出版者AMER MEDICAL ASSOC
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/128551]  
专题中国科学院合肥物质科学研究院
通讯作者Zong, Xiangyun
作者单位1.Shanghai Jiao Tong Univ, Affiliated Shanghai Peoples Hosp 6, Dept Breast Surg, 600 Yishan Rd, Shanghai 200233, Peoples R China
2.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Peoples R China
推荐引用方式
GB/T 7714
Yu, Yang,Zong, Xiangyun. Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial Reply[J]. JAMA ONCOLOGY,2022.
APA Yu, Yang,&Zong, Xiangyun.(2022).Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial Reply.JAMA ONCOLOGY.
MLA Yu, Yang,et al."Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial Reply".JAMA ONCOLOGY (2022).

入库方式: OAI收割

来源:合肥物质科学研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。